Assignee
CELL PATHWAYS INC
US·73 granted patents·1,789 citations·filing 1994–2002
Top patents by PatentIndex Score
73 records- 0196US6348032B1Method of inhibiting neoplastic cells with benzimidazole derivativesCELL PATHWAYS INC·Filed 1998·Granted Feb 19, 2002·117 cites·2 claims
- 0294US6046206AMethod of treating a patient having a precancerous lesions with amide quinazoline derivativesCELL PATHWAYS INC·Filed 1997·Granted Apr 4, 2000·150 cites·10 claims
- 0393US5948911AMethod for inhibiting neoplastic cells and related conditions by exposure to thienopyrimidine derivativesCELL PATHWAYS INC·Filed 1998·Granted Sep 7, 1999·69 cites·19 claims
- 0492US6358992B1Method of inhibiting neoplastic cells with indole derivativesCELL PATHWAYS INC·Filed 1999·Granted Mar 19, 2002·125 cites·14 claims
- 0592US6200980B1Method of treating a patient having precancerous lesions with phenyl purinone derivativesCELL PATHWAYS INC·Filed 1997·Granted Mar 13, 2001·60 cites·8 claims
- 0691US6380206B1Method of inhibiting neoplastic cells with 4,5-diaminopyrimidine derivativesCELL PATHWAYS INC·Filed 2001·Granted Apr 30, 2002·35 cites·6 claims
- 0791US6133271AMethod for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivativesCELL PATHWAYS INC·Filed 1998·Granted Oct 17, 2000·92 cites·12 claims
- 0890US6369092B1Method for treating neoplasia by exposure to substituted benzimidazole derivativesCELL PATHWAYS INC·Filed 2001·Granted Apr 9, 2002·32 cites·3 claims
- 0987US6166053ASubstituted condensation products of N-benzyl-3-idenylacetamides with heterocyclic aldehydes for neoplasiaCELL PATHWAYS INC·Filed 2000·Granted Dec 26, 2000·14 cites·2 claims
- 1087US5696159ALactone compounds for treating patients with precancerous lesionsCELL PATHWAYS INC·Filed 1994·Granted Dec 9, 1997·35 cites·18 claims
- 1186US6486158B1[4,5]-fused-3,6-disubstituted-pyridazines with sulfur-containing substituents in position three for the treatment of neoplasiaCELL PATHWAYS INC·Filed 2001·Granted Nov 26, 2002·17 cites·33 claims
- 1286US6211177B1Method for treating neoplasia by exposure to substituted 2-aryl-benzimidazole derivativesCELL PATHWAYS INC·Filed 1998·Granted Apr 3, 2001·86 cites·6 claims
- 1383US6420410B1Method for treating neoplasia by exposure to N,N′-substituted benzimidazol-2-onesCELL PATHWAYS INC·Filed 2000·Granted Jul 16, 2002·17 cites·7 claims
- 1483US6177471B1Method for treating patients with acne by administering a CGMP-specific PDE inhibitorCELL PATHWAYS INC·Filed 1999·Granted Jan 23, 2001·66 cites·1 claims
- 1582US6403831B1Substituted benzylidene indenyl formamides, acetamides and propionamidesCELL PATHWAYS INC·Filed 2000·Granted Jun 11, 2002·13 cites·1 claims
- 1682US6180629B1[4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasiaCELL PATHWAYS INC·Filed 1998·Granted Jan 30, 2001·28 cites·24 claims
- 1780US6410584B1Method for inhibiting neoplastic cells with indole derivativesCELL PATHWAYS INC·Filed 1998·Granted Jun 25, 2002·46 cites·2 claims
- 1880US5858694AMethod for identifying compounds for inhibition of cancerous lesionsCELL PATHWAYS INC·Filed 1997·Granted Jan 12, 1999·60 cites·26 claims
- 1979US6479493B1Methods for treatment of type I diabetesCELL PATHWAYS INC·Filed 2001·Granted Nov 12, 2002·12 cites·40 claims
- 2079US6300346B1Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesionsCELL PATHWAYS INC·Filed 2000·Granted Oct 9, 2001·7 cites·16 claims
- 2178US6262059B1Method of treating a patient having precancerous lesions with quinazoline derivativesCELL PATHWAYS INC·Filed 1998·Granted Jul 17, 2001·44 cites·19 claims
- 2277US6359002B2Method for treating a patient with neoplasia by treatment with a platinum coordination complexCELL PATHWAYS INC·Filed 2001·Granted Mar 19, 2002·4 cites·1 claims
- 2376US5990117AMethod for inhibiting neoplastic cells and related conditions by exposure to quinazoline derivativesCELL PATHWAYS INC·Filed 1998·Granted Nov 23, 1999·43 cites·10 claims
- 2476US5965619AMethod for treating patients having precancerous lesions with substituted indene derivativesCELL PATHWAYS INC·Filed 1997·Granted Oct 12, 1999·47 cites·29 claims
- 2574US6063818ASubstituted benzylidene indenyl formamides, acetamides and propionamidesCELL PATHWAYS INC·Filed 1997·Granted May 16, 2000·32 cites·47 claims
- 2673US6555547B1Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivativeCELL PATHWAYS INC·Filed 2000·Granted Apr 29, 2003·5 cites·17 claims
- 2772US6391885B1Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivativesCELL PATHWAYS INC·Filed 2000·Granted May 21, 2002·2 cites·4 claims
- 2871US5948779ASubstituted condensation products of n-benzyl-3-indenyl acetamides with heterocyclic aldehydesCELL PATHWAYS INC·Filed 1997·Granted Sep 7, 1999·13 cites·77 claims
- 2970US6465494B1Methods for treatment of cystic fibrosisCELL PATHWAYS INC·Filed 2001·Granted Oct 15, 2002·5 cites·37 claims
- 3070US6365627B2Method for treating a patient with neoplasia by treatment with a paclitaxel derivativeCELL PATHWAYS INC·Filed 2001·Granted Apr 2, 2002·1 cites·1 claims
- 3170US6066634ASubstituted condensation products of N-benzyl-3-indenylacetamides heterocyclic aldehydes for neoplasiaCELL PATHWAYS INC·Filed 1998·Granted May 23, 2000·12 cites·28 claims
- 3269US6472420B2Method for treating a patient with neoplasia by treatment with a paclitaxel derivativeCELL PATHWAYS INC·Filed 2002·Granted Oct 29, 2002·1 cites·3 claims
- 3368US5874440AMethod of treating a patient having precancerous lesions with phenyl pyrimidinone derivativesCELL PATHWAYS INC·Filed 1995·Granted Feb 23, 1999·27 cites·16 claims
- 3467US6500610B1Methods for identifying compounds for inhibiting of neoplastic lesions, and pharmaceutical compositions containing such compoundsCELL PATHWAYS INC·Filed 1999·Granted Dec 31, 2002·22 cites·12 claims
- 3567US6232312B1Method for treating patient having precancerous lesions with a combination of pyrimidopyrimidine derivatives and esters and amides of substituted indenyl acetic acidesCELL PATHWAYS INC·Filed 1998·Granted May 15, 2001·31 cites·14 claims
- 3666US6071934AIndenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesionsCELL PATHWAYS INC·Filed 1997·Granted Jun 6, 2000·25 cites·4 claims
- 3766US6028116ASubstituted condensation products of 1H-indenyl-hydroxyalkanes with aldehydes for neoplasiaCELL PATHWAYS INC·Filed 1998·Granted Feb 22, 2000·29 cites·52 claims
- 3866US5852035AMethod for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-aminesCELL PATHWAYS INC·Filed 1997·Granted Dec 22, 1998·28 cites·15 claims
- 3965US5942520AMethod for inhibiting neoplastic cells by exposure to substituted N-cycloalkylmethyl-1-H-pyrazolo (3,4-B) quinolone-4 aminesCELL PATHWAYS INC·Filed 1998·Granted Aug 24, 1999·27 cites·15 claims
- 4064US6121321ASubstituted methoxy benzylidene indenyl acetic and propionic acids for treating patients with precancerous lesionsCELL PATHWAYS INC·Filed 1996·Granted Sep 19, 2000·26 cites·23 claims
- 4164US5643959AMethod for treating patients with precancerous lesions by administering substituted sulfonyl indenyl acetic and propionic acids and esters thereofCELL PATHWAYS INC·Filed 1994·Granted Jul 1, 1997·17 cites·11 claims
- 4262US6486155B1Method of inhibiting neoplastic cells with isoquinoline derivativesCELL PATHWAYS INC·Filed 1998·Granted Nov 26, 2002·21 cites·2 claims
- 4361US6034099AMethod for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-onesCELL PATHWAYS INC·Filed 1998·Granted Mar 7, 2000·21 cites·9 claims
- 4460US6200771B1Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasiaCELL PATHWAYS INC·Filed 1998·Granted Mar 13, 2001·18 cites·13 claims
- 4560US6025394AMethod for treating patients with acne by administering substituted sulfonyl indenyl acetic acids, amides and alcoholsCELL PATHWAYS INC·Filed 1999·Granted Feb 15, 2000·22 cites·9 claims
- 4659US6235776B1Method for treating a patient with neoplasia by treatment with a paclitaxel derivativeCELL PATHWAYS INC·Filed 1998·Granted May 22, 2001·12 cites·10 claims
- 4758US6130053AMethod for selecting compounds for inhibition of neoplastic lesionsCELL PATHWAYS INC·Filed 1999·Granted Oct 10, 2000·20 cites·12 claims
- 4857US6160003A1,3,6-trihydro-6-aza-3-oxapentalen-2-one derivatives for the treatment of neoplasiaCELL PATHWAYS INC·Filed 1999·Granted Dec 12, 2000·5 cites·18 claims
- 4956US6479520B1Method of treating a patient having precancerous lesions with phenyl pyridinone derivativesCELL PATHWAYS INC·Filed 2000·Granted Nov 12, 2002·0 cites·7 claims
- 5056US6046199AMethod of inhibiting neoplastic cells with tetracyclic pyrido[3,4-B]indole derivativesCELL PATHWAYS INC·Filed 1998·Granted Apr 4, 2000·16 cites·12 claims
Showing the top 50 of 73 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CELL PATHWAYS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →